Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samra Turajlic

Showing results (41-50 of 126) with videos related to

Pageof 13
Sort By:
The British Journal of Dermatology|May 16, 2024
Increased incidence of co-trimoxazole-induced rash in patients on systemic corticosteroid treatment for toxicity associated with immune checkpoint inhibitorsDaniel Yiu, Silvia Aguilar-Duran, Charlotte Edwards, et al.
Cancer Discovery|April 3, 2021
Tracking Cancer Evolution through the Disease CourseChris Bailey, James R M Black, James L Reading, et al.
Cancer Cell|March 15, 2022
With one eye on the futureCarlos Caldas, Maria Rescigno, Samra Turajlic, et al.
Nature Reviews. Clinical Oncology|March 12, 2022
COVID-19 vaccines in patients with cancer: immunogenicity, efficacy and safetyAnnika Fendler, Elisabeth G E de Vries, Corine H GeurtsvanKessel, et al.
European Radiology|September 28, 2022
Optimisation of b-values for the accurate estimation of the apparent diffusion coefficient (ADC) in whole-body diffusion-weighted MRI in patients with metastatic melanomaAnnemarie K Knill, Matthew D Blackledge, Andra Curcean, et al.
ESMO Open|March 14, 2018
Contemporary outcomes from the use of regular imaging to detect relapse in high-risk cutaneous melanomaKok Haw Jonathan Lim, Lavinia Spain, Claire Barker, et al.
ESMO Open|July 10, 2020
Five-year review of corticosteroid duration and complications in the management of immune checkpoint inhibitor-related diarrhoea and colitis in advanced melanomaDavid M Favara, Lavinia Spain, Lewis Au, et al.
Pigment Cell & Melanoma Research|June 11, 2014
The mutational burden of acral melanoma revealed by whole-genome sequencing and comparative analysisSimon J Furney, Samra Turajlic, Gordon Stamp, et al.
Stem Cell Research|November 16, 2024
Generation of TWO iPSC lines (CRICKi009-A; CRICKi010-A) from patients with type 1 von Hippel-Lindau (VHL) and histopathologically confirmed renal cell carcinoma (RCC)Liani G Devito, Eugénie S Lim, Samuel M O'Toole, et al.
The Journal of Pathology|April 27, 2013
Genome sequencing of mucosal melanomas reveals that they are driven by distinct mechanisms from cutaneous melanomaSimon J Furney, Samra Turajlic, Gordon Stamp, et al.
Pageof 13

Showing results (41-50 of 126) with videos related to

Sort By:
Pageof 13
The British Journal of Dermatology|May 16, 2024
Increased incidence of co-trimoxazole-induced rash in patients on systemic corticosteroid treatment for toxicity associated with immune checkpoint inhibitorsDaniel Yiu, Silvia Aguilar-Duran, Charlotte Edwards, et al.
Cancer Discovery|April 3, 2021
Tracking Cancer Evolution through the Disease CourseChris Bailey, James R M Black, James L Reading, et al.
Cancer Cell|March 15, 2022
With one eye on the futureCarlos Caldas, Maria Rescigno, Samra Turajlic, et al.
Nature Reviews. Clinical Oncology|March 12, 2022
COVID-19 vaccines in patients with cancer: immunogenicity, efficacy and safetyAnnika Fendler, Elisabeth G E de Vries, Corine H GeurtsvanKessel, et al.
European Radiology|September 28, 2022
Optimisation of b-values for the accurate estimation of the apparent diffusion coefficient (ADC) in whole-body diffusion-weighted MRI in patients with metastatic melanomaAnnemarie K Knill, Matthew D Blackledge, Andra Curcean, et al.
ESMO Open|March 14, 2018
Contemporary outcomes from the use of regular imaging to detect relapse in high-risk cutaneous melanomaKok Haw Jonathan Lim, Lavinia Spain, Claire Barker, et al.
ESMO Open|July 10, 2020
Five-year review of corticosteroid duration and complications in the management of immune checkpoint inhibitor-related diarrhoea and colitis in advanced melanomaDavid M Favara, Lavinia Spain, Lewis Au, et al.
Pigment Cell & Melanoma Research|June 11, 2014
The mutational burden of acral melanoma revealed by whole-genome sequencing and comparative analysisSimon J Furney, Samra Turajlic, Gordon Stamp, et al.
Stem Cell Research|November 16, 2024
Generation of TWO iPSC lines (CRICKi009-A; CRICKi010-A) from patients with type 1 von Hippel-Lindau (VHL) and histopathologically confirmed renal cell carcinoma (RCC)Liani G Devito, Eugénie S Lim, Samuel M O'Toole, et al.
The Journal of Pathology|April 27, 2013
Genome sequencing of mucosal melanomas reveals that they are driven by distinct mechanisms from cutaneous melanomaSimon J Furney, Samra Turajlic, Gordon Stamp, et al.
Pageof 13